期刊文献+

血管紧张素Ⅱ-1型受体基因多态性与冠状动脉血管病变及支架内再狭窄的关系 被引量:3

The relationship between angiotensin Ⅱ type Ⅰ receptor gene polymorphism and coronary atherosclerosis and in-stent restenosis
下载PDF
导出
摘要 目的 :探讨血管紧张素 - 1型受体 (AT1 R)基因的 A116 6 C多态性与冠状血管动脉硬化进程以及支架术后血管内膜增殖的相关性。方法 :对 10 6例接受冠状动脉血管造影 (CAG)和支架术的患者 ,采用 PCR进行 A116 6 C多态性检测 ,并对其中 6 0例患者于半年内行 CAG随访 ,按 CAG结果分为再狭窄组与无再狭窄组。判定血管动脉硬化进程及再狭窄与 AT1 R A116 6 C多态性的相关性。结果 :10 6例患者中无 AT1 R CC基因型。 AT1 R AA和 AC型患者术前参照血管直径及最小管腔直径均无差异 ,血管平均狭窄程度也无差异 (P>0 .0 5 )。再狭窄组中 AA,AC和CC基因型频率分别为 0 .941,0 .0 5 9和 0 .0 0 0 ,而无再狭窄组分别为 0 .885 ,0 .115和 0 .0 0 0 ,两组间无显著性差异(χ2 =0 .6 17,P=0 .432 )。再狭窄组 116 6 C等位基因频率为 0 .0 2 9,无再狭窄组为 0 .0 5 8,无显著性差异 (χ2 =0 .5 9,P=0 .44 2 )。结论 :AT1 R A116 6 C多态性与血管动脉硬化进程及支架术后内膜的增殖无相关性。 AIM:To investigate the relationship between the angiotensin Ⅱ typeⅠ receptor gene and coronary atherosclerosis,and its effect on in-stent restenosis. METHODS:In this study AT 1R gene polymorphisms were investigated in 106 corpnary artery disease patients,among which 60 patients were again taken angiography in 6 months after stent placement. These polymorphisms were analysed by PCR and restriction fragment length polymorphism(RFLP). RESULTS:No AT 1R CC genotype was detected in our study. The study shows there were no statistically significant difference in reference diameter,minimal lumen diameter and the degree of mean segment diamter before PTCA between AT 1R AA and AC groups. In restenosis group,the AT 1R AA,AC and CC genetype frequenty were 0.941,0.059 and 0.000,against 0.885,0.115 and 0.000,respectively in nonrestenosis group ( χ 2=0.617,P=0.432). The frequency of 1166C allele was 0.029 in restenosis group against 0.058 in non-restenosis group(χ 2=0.59,P=0.442). CONCLUSION:The frequency of AT 1R genotype and C1166 allele was neither associated with the progression of coronary atherosclerosis nor with the in-stent restenosis.
出处 《心脏杂志》 CAS 2003年第4期303-305,共3页 Chinese Heart Journal
关键词 血管紧张素Ⅱ-1型受体 基因多态性 动脉硬化 再狭窄 angiotensin Ⅱ receptor type Ⅰ polymorphism atherosclerosis restenosis
  • 相关文献

参考文献7

  • 1Bonnardeaux A,Davies E,Jeunemaitre X,et al. Angiotensin I type I receptor gene polymorphisms in human essential hypertension[J]. Hypertension, 1994,24 : 63-- 69.
  • 2Katsuya T,Koite G,Yee TW,et al. Association of angiotensiogen T235 variant with increased risk of coronary heart disease [J]. Lancet, 1995,345 :1600-- 1603.
  • 3Furuta H,Deng-Fu Guo,Inagami T. Molecular cloning and sequending of he gene encoding human angiotensin I type 1 receptor[J]. Biochem Biophys Res Commun,1992,28:17--26.
  • 4Van Creel PP,Pinto YM,Voors A.A,et al. Angiotensin I type I receptor A1166C polymorphism is associated with an increased response to angiotensin I in human arteries[J]. Hypertension, 2000,35 : 717-- 721.
  • 5Carluccio M, Soccio M, De Caterina R, et al. Aspects of gene polymorphisms in cardiovascular diseases:the renin-angiogensin system[J]. Eur J Clin Invest,2001,31:1--14.
  • 6Tiert L,Bonnardeaux A,Poirier O,et al. Synergisitic effects of angiotensin converting enzyme and angiotensin I tyep 1 receptor gene plymorphisms on risk of myocardial infarction [J].Lancet, 1994,344 : 910-- 913.
  • 7Petes S,Gotting B,Trummel M,et al. Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial[J]. J Invasive Cardial , 2001,13 ( 2 ) :93--97.

同被引文献25

  • 1石琳,申阿东,李晓峰,柏松,关晓蕾,李仲智.中国先天性心脏病Nkx2.5基因突变筛查及关联研究[J].首都医科大学学报,2005,26(5):525-528. 被引量:19
  • 2谢学建,郭文怡,李兰荪,舒青,姜文瑞,张淑珍,李飞.Connexin37基因多态性与冠心病的相关性[J].心脏杂志,2006,18(5):539-541. 被引量:7
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5219
  • 4Wong TY,Cheung N,Islam FMA,et al.Relation of retinopathy to coronary artery calcification:the multi-ethnic study of atherosclerosis[J].Am J Epidemiol,2008,167(1):51-58.
  • 5Sun C,Liew G,Wang JJ,et al.Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an asian population:the singapore malay eye study[J].Invest Ophthalmol Vis Sci,2008,49(5):1784-1790.
  • 6Hubbard LD,Brothers RJ,King WN,et al.Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities (ARIC) study[J].Ophthalmology,1999,106(12):2269-2280.
  • 7Sabanayagam C,Tai ES,Lee J,et al. Retinal vessel caliber and peripheral neuropathy in diabetic articipants[J].Microcirculation,2010,17(4):297-302.
  • 8Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606-607.
  • 9Cheung N,Rogers S,Mosley TH,et al.Vital exhaustion and retinal microvascular changes in cardiovascular disease:atherosclerosis risk in communities study[J].Psychosom Med,2009,71(3):308-312.
  • 10Preiss D,Sattar N,McMurray JJ.A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design[J].Am Heart J,2011,161(1):210-219.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部